IBS FINANCIAL CORP
DFAN14A, 1997-07-15
SAVINGS INSTITUTIONS, NOT FEDERALLY CHARTERED
Previous: SPECIALTY TELECONSTRUCTORS INC, 8-K, 1997-07-15
Next: SIGNAL INVESTMENT & MANAGEMENT CO, 10-Q, 1997-07-15




<PAGE>
SCHEDULE 14A
                                 (Rute 14A-101)
                     INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION
                Proxy Statement Pursuant to Section 14 (a) of the
                         Securities Exchange Act of 1934
                                (Amendment No. )

Filed by the Registrant [ ]
Filed by a Party other than the Registrant [x] Check the appropriate box:
Preliminary Proxy Statement [ ]
Confidential, for Use of the
Commission  Only  (as  permitted  by  Rule  14a-6(e)  (2) [ ]  Definitive  Proxy
statement [ ] Definitive  Additional  Materials [X] Soliciting Material Pursuant
to Rule 14a-11 (c) or Rule 14a-12

                               IBS FINANCIAL CORP.
- -------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)

                     COMMITTEE TO MAXIMIZE SHAREHOLDER VALUE
- -------------------------------------------------------------------------------
(Name of Person (s) filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
[        ] $125 per Exchange Act Rules 0-11 (c) (1)(ii), 14a-6(1),  14a-6(i) (2)
         or Item 22 (a) (2) of Schedule 14A.
[    ] $500 per each party to the  controversy  pursuant  to  Exchange  Act Rule
     14a-6 (I) (3).
[  ] Fee computed on table below per Exchange Act Rules 14 (a)-6(i) (4) and
     0-11.

         1) Title of each class of securities to which transaction applies:

         ----------------------------------------------------------------------

         2) Aggregate number of securites to which transaction applies:

         ----------------------------------------------------------------------
         3) Per unit price or other  underlying  value of  transaction  computed
          pursuant to Exchange  Act Rule 0-11 (set forth the amount on which the
          filing fee is calculated and state how it was determined):

         ----------------------------------------------------------------------
         4) Proposed maximum aggregate value of transaction:

         ----------------------------------------------------------------------

         5) Total Fee Paid:
         ----------------------------------------------------------------------
[  ]  Fee paid previously with preliminary materials.

- -------------------------------------------------------------------------------
[  ]     Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a) (2) and identify the filing for which the offsetting fee was
paid previously.  Identify the previous filing  by registration statement
 number, or the Form or Schedule and the date of its filing.

         1) Amount Previously Paid:

         ----------------------------------------------------------------------
         2) Form, Schedule or Registration Statement No.:

         ----------------------------------------------------------------------
         3) Filing Party:

         ----------------------------------------------------------------------
         4) Date Filed:

          ---------------------------------------------------------------------
<PAGE>



                                Ernest Beier, Jr.
                               1609 Ravenswood Way
                              Cherry Hill, NJ 08003
                                 (609) 424-1690
                                  July 14, 1997

Dear Fellow IBS Financial Corp. Shareholder:

     My name is  Ernest  Beier and I have been a  shareholder  of IBS  Financial
Corp. since October 1994, at the time the Company first became public. I was not
acquainted with any members of the so-called "Opposition Group" before the first
proxy contest in December 1995. I have watched the earnings of the bank stagnate
while the  earnings of other local  financial  institutions  have  significantly
increased.  I am  writing  to you today  both as a fellow  shareholder  and as a
nominee for the Board of IBS.

     Since 1972 I have been  affiliated  with various  banks in the South Jersey
area, as a director,  chairman,  Chief Executive  Officer or president.  Each of
these banks had successful growth records and each of them was ultimately merged
into another  financial  institution.  The  shareholders of these companies were
rewarded  because they had a Board and  management  team that took the necessary
steps to maximize value. I believe IBS now needs more effective leadership,  and
a change of direction, in order to maximize value for its shareholders.

     I have a proven record of creating  shareholder  value.  In my opinion IBS'
earnings are an embarrassment and current  management is not taking advantage of
possible opportunities to maximize shareholder value. Instead current management
is slinging mud at a person who is not even running for a seat on the Board. IBS
has not said a negative  thing about  Richard  Whitman or me, the two people who
will be representing you, because IBS can not.

     It is not an easy  decision  to join a  so-called  "opposition  group"  and
subject yourself to castigation by the incumbent management. I did not make this
decision lightly.  However,  I believe I can bring an experience and independent
voice to the IBS  Board.  I believe  the same can be said of my fellow  nominee,
Richard Whitman.  We can bring years of financial and banking  experience to IBS
and  hopefully  be a  catalyst  for  change - a change  that  will  benefit  all
shareholders.

     You may ask why, in light of IBS'  continued  attacks on Larry  Seidman and
the Committee to Maximize  Shareholder  Value,  have I agreed to be part of this
effort to bring new  direction  to IBS?  The answer is simple:  I agree with the
Committee's ideas and goals.

     I agree with the Committee  that IBS should  retain an  investment  banking
     firm for the express purpose of seeking ways to maximize shareholder value.
     This may include the sale of IBS, or an  acquisition  of another  financial
     institution, as well as other alternatives.

     I also agree with the Committee that the compensation  levels for the chief
     executive,   and  the  directors,   are  troublesome  when  you  take  into
     consideration  the  relatively  small  size of the bank,  and the  mediocre
     results it has achieved.

     In my opinion,  the stock price of IBS is trading at an  artificially  high
     level due to one of several  factors  including,  but not  limited  to, the
     general  interest  in banks as  takeover  candidates,  the IBS' open market
     share repurchase  program, or the market's reaction to the possibility that
     the Committee  will be successful in placing  independent  Directors on the
     Board  who  will  work  to  maximize  shareholder  value.  I  believe  this
     environment  will not  last  forever.  Unless  we take  steps  to  maximize
     shareholder value now, we may lose a golden opportunity.

     In short,  I don't believe IBS' operating  record,  under the current Board
and management  team should  inspire  shareholder  confidence.  If the Company's
stock has to trade on fundamentals  alone,  we, in my opinion,  will probably be
looking at a lower stock price.

     I urge you to support my candidacy as an  independent  director  along with
that of my fellow  nominee  Richard  Whitman by signing and  returning the white
proxy card today.  Richard  has spent over 25 years in the world of finance.  In
light of our long and successful careers, I believe you can count of on us to be
independent voices on the Board of Directors.
                                                     Sincerely,


                                                     Ernest Beier

     P.S. If you need  assistance  in voting  your  shares,  please  contact our
     solicitors, Beacon Hill Partners, at 1-800-755-5001.

     P.P.S.   The  outstanding   share  amount  of  11,609,723   stated  in  the
     Supplemental Factual Information to Proxy Statement Dated March 24, 1997 is
     hereby corrected to be 11,011,897.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission